nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—ABCB1—adrenal gland cancer	0.67	1	CbGaD
Carfilzomib—PSMB10—adrenal gland—adrenal gland cancer	0.00755	0.0837	CbGeAlD
Carfilzomib—PSMB8—adrenal cortex—adrenal gland cancer	0.00674	0.0747	CbGeAlD
Carfilzomib—PSMB5—adrenal cortex—adrenal gland cancer	0.00595	0.066	CbGeAlD
Carfilzomib—PSMB8—pituitary gland—adrenal gland cancer	0.00545	0.0604	CbGeAlD
Carfilzomib—PSMB1—adrenal cortex—adrenal gland cancer	0.0052	0.0577	CbGeAlD
Carfilzomib—PSMB2—adrenal cortex—adrenal gland cancer	0.00508	0.0563	CbGeAlD
Carfilzomib—PSMB5—cardiac atrium—adrenal gland cancer	0.00492	0.0546	CbGeAlD
Carfilzomib—PSMB8—adrenal gland—adrenal gland cancer	0.00487	0.0539	CbGeAlD
Carfilzomib—PSMB5—pituitary gland—adrenal gland cancer	0.00481	0.0533	CbGeAlD
Carfilzomib—PSMB1—gonad—adrenal gland cancer	0.00431	0.0478	CbGeAlD
Carfilzomib—PSMB1—cardiac atrium—adrenal gland cancer	0.0043	0.0477	CbGeAlD
Carfilzomib—PSMB5—adrenal gland—adrenal gland cancer	0.0043	0.0476	CbGeAlD
Carfilzomib—PSMB2—gonad—adrenal gland cancer	0.00421	0.0466	CbGeAlD
Carfilzomib—PSMB1—pituitary gland—adrenal gland cancer	0.0042	0.0466	CbGeAlD
Carfilzomib—PSMB2—cardiac atrium—adrenal gland cancer	0.0042	0.0465	CbGeAlD
Carfilzomib—PSMB2—pituitary gland—adrenal gland cancer	0.0041	0.0455	CbGeAlD
Carfilzomib—PSMB1—adrenal gland—adrenal gland cancer	0.00376	0.0416	CbGeAlD
Carfilzomib—PSMB2—adrenal gland—adrenal gland cancer	0.00367	0.0406	CbGeAlD
Carfilzomib—Lopinavir—ABCB1—adrenal gland cancer	0.00186	0.543	CrCbGaD
Carfilzomib—Ritonavir—ABCB1—adrenal gland cancer	0.00156	0.457	CrCbGaD
Carfilzomib—ABCB1—adrenal cortex—adrenal gland cancer	0.000776	0.0086	CbGeAlD
Carfilzomib—ABCB1—gonad—adrenal gland cancer	0.000642	0.00712	CbGeAlD
Carfilzomib—ABCB1—pituitary gland—adrenal gland cancer	0.000627	0.00695	CbGeAlD
Carfilzomib—ABCB1—adrenal gland—adrenal gland cancer	0.00056	0.00621	CbGeAlD
Carfilzomib—PSMB10—Signaling Pathways—MEN1—adrenal gland cancer	0.00014	0.000592	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CDC42—adrenal gland cancer	0.000139	0.00059	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—MEN1—adrenal gland cancer	0.000139	0.00059	CbGpPWpGaD
Carfilzomib—PSMB10—Cell Cycle—CDKN2A—adrenal gland cancer	0.000138	0.000586	CbGpPWpGaD
Carfilzomib—PSMB9—Cell Cycle—CDKN2A—adrenal gland cancer	0.000138	0.000583	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling by Wnt—CTNNB1—adrenal gland cancer	0.000135	0.000572	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling by Wnt—CTNNB1—adrenal gland cancer	0.000135	0.000572	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling by Wnt—CTNNB1—adrenal gland cancer	0.000135	0.000572	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle, Mitotic—RB1—adrenal gland cancer	0.000133	0.000565	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle, Mitotic—RB1—adrenal gland cancer	0.000133	0.000565	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle, Mitotic—RB1—adrenal gland cancer	0.000133	0.000565	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling by Wnt—CTNNB1—adrenal gland cancer	0.000133	0.000564	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—MED12—adrenal gland cancer	0.000133	0.000562	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—MED12—adrenal gland cancer	0.000133	0.000562	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—MED12—adrenal gland cancer	0.000133	0.000562	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle, Mitotic—RB1—adrenal gland cancer	0.000131	0.000557	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—MED12—adrenal gland cancer	0.000131	0.000554	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—CDC42—adrenal gland cancer	0.000129	0.000548	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—CDC42—adrenal gland cancer	0.000129	0.000545	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—PRKACA—adrenal gland cancer	0.000128	0.000541	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—PRKACA—adrenal gland cancer	0.000127	0.000538	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—GNRH1—adrenal gland cancer	0.000126	0.000536	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000126	0.000536	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—GNRH1—adrenal gland cancer	0.000126	0.000536	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—PRKACA—adrenal gland cancer	0.000125	0.00053	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—PRKACA—adrenal gland cancer	0.000125	0.00053	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—PRKACA—adrenal gland cancer	0.000125	0.00053	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—GNRH1—adrenal gland cancer	0.000125	0.000528	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—PRKACA—adrenal gland cancer	0.000123	0.000523	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—BAD—adrenal gland cancer	0.000122	0.000517	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—BAD—adrenal gland cancer	0.000122	0.000517	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—BAD—adrenal gland cancer	0.000122	0.000517	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—BAD—adrenal gland cancer	0.00012	0.00051	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle—RB1—adrenal gland cancer	0.000119	0.000505	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle—RB1—adrenal gland cancer	0.000119	0.000505	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle—RB1—adrenal gland cancer	0.000119	0.000505	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle—RB1—adrenal gland cancer	0.000118	0.000498	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	0.000117	0.000497	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	0.000117	0.000497	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	0.000117	0.000497	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000116	0.00049	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—SPRY2—adrenal gland cancer	0.000116	0.00049	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000116	0.00049	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	0.000116	0.00049	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—PRKACA—adrenal gland cancer	0.000115	0.000489	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—PRKACA—adrenal gland cancer	0.000115	0.000489	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—PRKACA—adrenal gland cancer	0.000115	0.000489	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—SPRY2—adrenal gland cancer	0.000114	0.000483	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—PRKACA—adrenal gland cancer	0.000114	0.000482	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TSHR—adrenal gland cancer	0.000113	0.000477	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TSHR—adrenal gland cancer	0.000113	0.000477	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TSHR—adrenal gland cancer	0.000113	0.000477	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TSHR—adrenal gland cancer	0.000111	0.000471	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—PRKACA—adrenal gland cancer	0.000107	0.000452	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—PRKACA—adrenal gland cancer	0.000106	0.00045	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CDC42—adrenal gland cancer	0.000106	0.00045	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CDC42—adrenal gland cancer	0.000106	0.00045	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CDC42—adrenal gland cancer	0.000106	0.00045	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MEN1—adrenal gland cancer	0.000106	0.000449	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MEN1—adrenal gland cancer	0.000106	0.000449	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MEN1—adrenal gland cancer	0.000106	0.000449	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle—CDKN2A—adrenal gland cancer	0.000105	0.000444	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle—CDKN2A—adrenal gland cancer	0.000105	0.000444	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle—CDKN2A—adrenal gland cancer	0.000105	0.000444	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CDC42—adrenal gland cancer	0.000105	0.000443	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MEN1—adrenal gland cancer	0.000104	0.000443	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—TERT—adrenal gland cancer	0.000104	0.000439	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—GNAS—adrenal gland cancer	0.000103	0.000438	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle—CDKN2A—adrenal gland cancer	0.000103	0.000438	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—TERT—adrenal gland cancer	0.000103	0.000437	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—GNAS—adrenal gland cancer	0.000103	0.000436	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—ABCB1—adrenal gland cancer	0.000102	0.00043	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—ABCB1—adrenal gland cancer	0.000101	0.000428	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CDC42—adrenal gland cancer	9.8e-05	0.000415	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CDC42—adrenal gland cancer	9.8e-05	0.000415	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CDC42—adrenal gland cancer	9.8e-05	0.000415	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—BAD—adrenal gland cancer	9.77e-05	0.000414	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—BAD—adrenal gland cancer	9.72e-05	0.000412	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PRKACA—adrenal gland cancer	9.67e-05	0.00041	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PRKACA—adrenal gland cancer	9.67e-05	0.00041	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PRKACA—adrenal gland cancer	9.67e-05	0.00041	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CDC42—adrenal gland cancer	9.66e-05	0.000409	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PRKACA—adrenal gland cancer	9.54e-05	0.000404	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	9.06e-05	0.000384	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CDC42—adrenal gland cancer	9.05e-05	0.000384	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—BAD—adrenal gland cancer	9.02e-05	0.000382	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CDC42—adrenal gland cancer	9.01e-05	0.000382	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—BAD—adrenal gland cancer	8.98e-05	0.00038	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IGF2—adrenal gland cancer	8.73e-05	0.00037	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IGF2—adrenal gland cancer	8.68e-05	0.000368	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—GNAS—adrenal gland cancer	8.65e-05	0.000366	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—GNAS—adrenal gland cancer	8.61e-05	0.000365	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IGF1R—adrenal gland cancer	8.44e-05	0.000357	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—EGFR—adrenal gland cancer	8.4e-05	0.000356	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IGF1R—adrenal gland cancer	8.4e-05	0.000356	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—EGFR—adrenal gland cancer	8.36e-05	0.000354	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—BRAF—adrenal gland cancer	8.21e-05	0.000348	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—BRAF—adrenal gland cancer	8.17e-05	0.000346	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—SDHB—adrenal gland cancer	8.12e-05	0.000344	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PRKACA—adrenal gland cancer	8.09e-05	0.000343	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—PRKACA—adrenal gland cancer	8.09e-05	0.000343	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PRKACA—adrenal gland cancer	8.09e-05	0.000343	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PRKACA—adrenal gland cancer	7.97e-05	0.000338	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—TERT—adrenal gland cancer	7.86e-05	0.000333	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—TERT—adrenal gland cancer	7.86e-05	0.000333	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—TERT—adrenal gland cancer	7.86e-05	0.000333	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—GNAS—adrenal gland cancer	7.84e-05	0.000332	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—GNAS—adrenal gland cancer	7.84e-05	0.000332	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—GNAS—adrenal gland cancer	7.84e-05	0.000332	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—TERT—adrenal gland cancer	7.75e-05	0.000328	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—GNAS—adrenal gland cancer	7.73e-05	0.000327	CbGpPWpGaD
Carfilzomib—PSMB10—Cell Cycle—TP53—adrenal gland cancer	7.7e-05	0.000326	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—ABCB1—adrenal gland cancer	7.69e-05	0.000326	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—ABCB1—adrenal gland cancer	7.69e-05	0.000326	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—ABCB1—adrenal gland cancer	7.69e-05	0.000326	CbGpPWpGaD
Carfilzomib—PSMB9—Cell Cycle—TP53—adrenal gland cancer	7.66e-05	0.000325	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—ABCB1—adrenal gland cancer	7.58e-05	0.000321	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—BAD—adrenal gland cancer	7.41e-05	0.000314	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—BAD—adrenal gland cancer	7.41e-05	0.000314	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—BAD—adrenal gland cancer	7.41e-05	0.000314	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—BAD—adrenal gland cancer	7.3e-05	0.000309	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TERT—adrenal gland cancer	7.26e-05	0.000308	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TERT—adrenal gland cancer	7.23e-05	0.000306	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—POMC—adrenal gland cancer	6.97e-05	0.000295	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—POMC—adrenal gland cancer	6.93e-05	0.000294	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CDC42—adrenal gland cancer	6.86e-05	0.000291	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CDC42—adrenal gland cancer	6.86e-05	0.000291	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CDC42—adrenal gland cancer	6.86e-05	0.000291	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—BAD—adrenal gland cancer	6.84e-05	0.00029	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—BAD—adrenal gland cancer	6.84e-05	0.00029	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—BAD—adrenal gland cancer	6.84e-05	0.00029	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CDC42—adrenal gland cancer	6.76e-05	0.000287	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—BAD—adrenal gland cancer	6.74e-05	0.000286	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	6.66e-05	0.000282	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—PTGS2—adrenal gland cancer	6.63e-05	0.000281	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IGF2—adrenal gland cancer	6.61e-05	0.00028	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IGF2—adrenal gland cancer	6.61e-05	0.00028	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IGF2—adrenal gland cancer	6.61e-05	0.00028	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—PTGS2—adrenal gland cancer	6.6e-05	0.00028	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—GNAS—adrenal gland cancer	6.56e-05	0.000278	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—GNAS—adrenal gland cancer	6.56e-05	0.000278	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—GNAS—adrenal gland cancer	6.56e-05	0.000278	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IGF2—adrenal gland cancer	6.52e-05	0.000276	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—GNAS—adrenal gland cancer	6.46e-05	0.000274	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CTNNB1—adrenal gland cancer	6.43e-05	0.000272	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CTNNB1—adrenal gland cancer	6.4e-05	0.000271	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IGF1R—adrenal gland cancer	6.39e-05	0.000271	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IGF1R—adrenal gland cancer	6.39e-05	0.000271	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IGF1R—adrenal gland cancer	6.39e-05	0.000271	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—EGFR—adrenal gland cancer	6.36e-05	0.00027	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—EGFR—adrenal gland cancer	6.36e-05	0.00027	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—EGFR—adrenal gland cancer	6.36e-05	0.00027	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—BAD—adrenal gland cancer	6.32e-05	0.000268	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IGF1R—adrenal gland cancer	6.3e-05	0.000267	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—BAD—adrenal gland cancer	6.29e-05	0.000266	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—EGFR—adrenal gland cancer	6.27e-05	0.000266	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—BRAF—adrenal gland cancer	6.22e-05	0.000264	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—BRAF—adrenal gland cancer	6.22e-05	0.000264	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—BRAF—adrenal gland cancer	6.22e-05	0.000264	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—BRAF—adrenal gland cancer	6.14e-05	0.00026	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	6.08e-05	0.000257	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	5.96e-05	0.000253	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—CTNNB1—adrenal gland cancer	5.94e-05	0.000251	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—CTNNB1—adrenal gland cancer	5.91e-05	0.00025	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle—TP53—adrenal gland cancer	5.83e-05	0.000247	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle—TP53—adrenal gland cancer	5.83e-05	0.000247	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle—TP53—adrenal gland cancer	5.83e-05	0.000247	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—POMC—adrenal gland cancer	5.82e-05	0.000247	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—POMC—adrenal gland cancer	5.8e-05	0.000246	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—BRAF—adrenal gland cancer	5.75e-05	0.000244	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle—TP53—adrenal gland cancer	5.75e-05	0.000244	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—BRAF—adrenal gland cancer	5.72e-05	0.000243	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—PTGS2—adrenal gland cancer	5.56e-05	0.000235	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—PTGS2—adrenal gland cancer	5.53e-05	0.000234	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TERT—adrenal gland cancer	5.5e-05	0.000233	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TERT—adrenal gland cancer	5.5e-05	0.000233	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TERT—adrenal gland cancer	5.5e-05	0.000233	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TERT—adrenal gland cancer	5.43e-05	0.00023	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—POMC—adrenal gland cancer	5.28e-05	0.000224	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—POMC—adrenal gland cancer	5.28e-05	0.000224	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—POMC—adrenal gland cancer	5.28e-05	0.000224	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—RRM1—adrenal gland cancer	5.23e-05	0.000222	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—SDHD—adrenal gland cancer	5.23e-05	0.000222	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—POMC—adrenal gland cancer	5.2e-05	0.00022	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—EGFR—adrenal gland cancer	5.09e-05	0.000216	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—EGFR—adrenal gland cancer	5.07e-05	0.000215	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—PTGS2—adrenal gland cancer	5.03e-05	0.000213	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—PTGS2—adrenal gland cancer	5.03e-05	0.000213	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—PTGS2—adrenal gland cancer	5.03e-05	0.000213	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—PTGS2—adrenal gland cancer	4.96e-05	0.00021	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	4.92e-05	0.000209	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CTNNB1—adrenal gland cancer	4.87e-05	0.000206	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CTNNB1—adrenal gland cancer	4.87e-05	0.000206	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CTNNB1—adrenal gland cancer	4.87e-05	0.000206	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CTNNB1—adrenal gland cancer	4.8e-05	0.000204	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—BAD—adrenal gland cancer	4.79e-05	0.000203	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—BAD—adrenal gland cancer	4.79e-05	0.000203	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—BAD—adrenal gland cancer	4.79e-05	0.000203	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	4.72e-05	0.0002	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—BAD—adrenal gland cancer	4.72e-05	0.0002	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—EGFR—adrenal gland cancer	4.7e-05	0.000199	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—EGFR—adrenal gland cancer	4.68e-05	0.000198	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CTNNB1—adrenal gland cancer	4.5e-05	0.000191	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CTNNB1—adrenal gland cancer	4.5e-05	0.000191	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CTNNB1—adrenal gland cancer	4.5e-05	0.000191	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CTNNB1—adrenal gland cancer	4.43e-05	0.000188	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—POMC—adrenal gland cancer	4.41e-05	0.000187	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—POMC—adrenal gland cancer	4.41e-05	0.000187	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—POMC—adrenal gland cancer	4.41e-05	0.000187	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—BRAF—adrenal gland cancer	4.36e-05	0.000185	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—BRAF—adrenal gland cancer	4.36e-05	0.000185	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—BRAF—adrenal gland cancer	4.36e-05	0.000185	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—POMC—adrenal gland cancer	4.35e-05	0.000184	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—BRAF—adrenal gland cancer	4.3e-05	0.000182	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PTGS2—adrenal gland cancer	4.21e-05	0.000178	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PTGS2—adrenal gland cancer	4.21e-05	0.000178	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PTGS2—adrenal gland cancer	4.21e-05	0.000178	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CTNNB1—adrenal gland cancer	4.16e-05	0.000176	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PTGS2—adrenal gland cancer	4.15e-05	0.000176	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CTNNB1—adrenal gland cancer	4.14e-05	0.000175	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	3.96e-05	0.000168	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—MED12—adrenal gland cancer	3.9e-05	0.000165	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—EGFR—adrenal gland cancer	3.86e-05	0.000164	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—EGFR—adrenal gland cancer	3.86e-05	0.000164	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—EGFR—adrenal gland cancer	3.86e-05	0.000164	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—EGFR—adrenal gland cancer	3.81e-05	0.000161	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—EGFR—adrenal gland cancer	3.56e-05	0.000151	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—EGFR—adrenal gland cancer	3.56e-05	0.000151	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—EGFR—adrenal gland cancer	3.56e-05	0.000151	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—EGFR—adrenal gland cancer	3.51e-05	0.000149	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—EGFR—adrenal gland cancer	3.29e-05	0.00014	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—EGFR—adrenal gland cancer	3.28e-05	0.000139	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CTNNB1—adrenal gland cancer	3.15e-05	0.000133	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CTNNB1—adrenal gland cancer	3.15e-05	0.000133	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CTNNB1—adrenal gland cancer	3.15e-05	0.000133	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CTNNB1—adrenal gland cancer	3.11e-05	0.000132	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PRKACA—adrenal gland cancer	2.85e-05	0.000121	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TP53—adrenal gland cancer	2.76e-05	0.000117	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TP53—adrenal gland cancer	2.75e-05	0.000117	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—EGFR—adrenal gland cancer	2.5e-05	0.000106	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—EGFR—adrenal gland cancer	2.5e-05	0.000106	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—EGFR—adrenal gland cancer	2.5e-05	0.000106	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—EGFR—adrenal gland cancer	2.46e-05	0.000104	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GNAS—adrenal gland cancer	2.31e-05	9.77e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TP53—adrenal gland cancer	2.1e-05	8.88e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TP53—adrenal gland cancer	2.1e-05	8.88e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TP53—adrenal gland cancer	2.1e-05	8.88e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TP53—adrenal gland cancer	2.07e-05	8.75e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—POMC—adrenal gland cancer	1.55e-05	6.58e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.24e-05	5.25e-05	CbGpPWpGaD
